Health
Research Alert: Glp-1 Drugs Linked To Dramatically Lower Death Rates In Colon Cancer Patients
By EurekAlert!
A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists — the class of drugs behind Ozempic, Wegovy and Mounjaro, for example — may do more than regulate blood sugar and weight. ...Read more